Lanxess to be spun off to stockholders

19 July 2004

At their meeting on July 16th, the Board of Management of Bayer AG decided that the Lanxess unit, currently operating as a Bayer subgroup, should be spun off to the company's stockholders and listed separately on the stock exchange at the beginning of 2005. 'In the current stock market climate, a spin-off to Bayer stockholders is the best route to a listing for Lanxess. The present owners of Bayer's assets automatically remain the owners of the assets being transferred to Lanxess', explained Bayer ceo Werner Wenning. Bayer had postponed a decision on whether to launch Lanxess by way of an initial public offering or a spin-off to stockholders in order to await capital market developments. 'We wanted to clarify the situation and at the same time ensure that the transaction would be fully accomplished', Wenning added. Lanxess ceo-designate Dr Axel C Heitmann says he is pleased that the Board decision has now been made. 'We want to instil confidence in our future stockholders and convince them that Lanxess stock is a worthwhile investment.' Bayer's stockholders will take the final decision on the spin-off at an Extraordinary Stockholders' Meeting expected to be held in mid-November 2004.

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.